Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S(SG:T14)
$2.55-0.06 (-2.30%)
SG:T14
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S financials statements
$2.55
At close:-0.06 (-2.30%)
Want to see SG:T14 full AI Analyst Report?
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (T14) Income Statement
8 Followers
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Income Statement
Last quarter (Q3 2026), Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S's total revenue was ¥963.16M, a decrease of 5.01% from the same quarter last year. In Q3, Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S's net income was ¥272.07M. See Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ¥ 4.92B | ¥ 7.31B | ¥ 8.22B | ¥ 8.25B | ¥ 6.91B | |
| ¥ 3.64B | ¥ 3.52B | ¥ 3.62B | ¥ 3.29B | ¥ 2.76B | |
| ¥ 1.15B | ¥ 953.99M | ¥ 2.49B | ¥ 2.57B | ¥ 2.14B | |
| Depreciation and Amortization | ¥ 115.66M | ¥ 125.94M | ¥ 130.13M | ¥ 116.56M | ¥ 115.53M |
| ¥ 2.61B | ¥ 2.74B | ¥ 1.26B | ¥ 1.11B | ¥ 991.28M | |
| ¥ 2.49B | ¥ 2.57B | ¥ 1.10B | ¥ 980.05M | ¥ 866.68M | |
| ¥ -2.14M | ¥ 12.06M | ¥ -1.61M | ¥ 138.80K | ¥ 6.13M | |
| ¥ 2.49B | ¥ 2.58B | ¥ 1.10B | ¥ 980.19M | ¥ 872.81M | |
| ¥ 2.13B | ¥ 2.23B | ¥ 986.71M | ¥ 861.79M | ¥ 769.14M | |
| Per Share Metrics | |||||
| Basic EPS | ¥ 2.77 | ¥ 2.90 | ¥ 1.28 | ¥ 1.12 | ¥ 1.00 |
| Diluted EPS | ¥ 2.77 | ¥ 2.90 | ¥ 1.28 | ¥ 1.11 | ¥ 1.00 |
| Weighted Average Shares Outstanding | 769.32M | 768.87M | 770.87M | 768.87M | 768.87M |
| Weighted Average Shares Outstanding (Diluted) | 769.32M | 768.87M | 770.87M | 776.39M | 768.87M |
Currency in CNY
